![The breaking news round-up: Decagear launches today, Pimax announces new headsets, and more! [APRIL FOOL’S]](https://i0.wp.com/skarredghost.com/wp-content/uploads/2025/03/lawk_glasses_handson.jpg?fit=1366%2C1025&ssl=1)
Another TIGIT trial fails as BeiGene scraps Phase 3 drug
What was once a promising area of cancer immunotherapy has had another late-stage failure. BeiGene said Thursday that a Phase 3 study for its anti-TIGIT drug, called ociperlimab, was halted for ...
What was once a promising area of cancer immunotherapy has had another late-stage failure.
BeiGene said Thursday that a Phase 3 study for its anti-TIGIT drug, called ociperlimab, was halted for ...
